Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition

By Tariq I. Mughal   John M. Goldman  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K.   Szilard Amy K.   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite

Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse

By Baumann M.   Krause M.   Zips D.   Eicheler W.   Dörfler A.   Ahrens J.   Petersen C.   Brüchner K.   Hilberg F.  

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 547-559

Informa Healthcare

Access to resources Recommend Favorite

Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor

By Kimura Shinya   Niwa Tomoko   Hirabayashi Kazuko   Maekawa Taira  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite

Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor

By Kimura Shinya   Niwa Tomoko   Hirabayashi Kazuko   Maekawa Taira  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite